June 13, 2019
Dr. Richard Horowitz, the medical director of the Hudson Valley Healing Arts Center in Hyde Park, NY, recently presented to NatCapLyme and reflected upon his experiences in treating chronic Lyme disease patients. In his talk, Dr Horowitz discussed two of his brand new scientific studies with broad implications for the diagnosis and treatment of Lyme disease and associated co-infections. In particular, his studies focus on two drugs – Dapsone (diaminodiphenyl sulfone, i.e. DDS) and Pyrazinamide – to combat the persistent form of Lyme disease and co-infections. He further explained how his Multiple Systemic Infectious Disease Syndrome (MSIDS) model and the use of these persister drugs represent new effective therapeutic options in tick-borne disorders.
Dr. Richard Horowitz, one of the country’s prominent Lyme and tick-borne disease specialists, recently made a presentation to the National Capital Lyme Disease Association. The title of his presentation was: Precision Medicine for Chronic Lyme and Multiple Systemic Infectious Disease Syndrome (MSIDS).
- Richard Horowitz, M.D. at Hudson Valley Healing Arts Center